Representative graphic displays of pyrexia scores by algorithm 5.0 of all analyzed patients over time; First data set, used for optimization of the pyrexia score algorithm. حسب Hannah Schaefer (13410637)

The structure of genetic algorithm (GA). حسب Ali Akbar Moosavi (17769033)

"…Then, radial basis functions (RBFNNs), multilayer perceptron (MLPNNs), hybrid genetic algorithm (GA-NNs), and particle swarm optimization (PSO-NNs) neural networks were utilized to develop PTFs and compared their accuracy with the traditional regression model (MLR) using statistical indices. …"

Optimal image settings for object detection of Iba1 immunolabelled cells in DAB. حسب Danish M. Anwer (15383441)

Optimized model prediction performance. حسب Guang Tu (22054865)

S1 Data - حسب Alexander Eckers (19106390)

"…</p><p>Methods</p><p>The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. …"

Personal algorithmic recommendations of potassium and phosphorous intake and the corresponding concentration predictions. حسب Jari Turkia (17912475)

Basic characteristics and intraoperative data. حسب Alexander Eckers (19106390)

"…</p><p>Methods</p><p>The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. …"

Von Willebrand parameters over time. حسب Alexander Eckers (19106390)

"…</p><p>Methods</p><p>The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. …"

Standard coagulation parameters. حسب Alexander Eckers (19106390)

"…</p><p>Methods</p><p>The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. …"

Blood loss and transfusion requirements. حسب Alexander Eckers (19106390)

"…</p><p>Methods</p><p>The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. …"

Standard coagulation parameters over time. حسب Alexander Eckers (19106390)

"…</p><p>Methods</p><p>The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. …"

Von Willebrand parameters. حسب Alexander Eckers (19106390)

"…</p><p>Methods</p><p>The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. …"

S1 Data - حسب Ali Akbar Moosavi (17769033)

"…Then, radial basis functions (RBFNNs), multilayer perceptron (MLPNNs), hybrid genetic algorithm (GA-NNs), and particle swarm optimization (PSO-NNs) neural networks were utilized to develop PTFs and compared their accuracy with the traditional regression model (MLR) using statistical indices. …"

List of data tables. حسب Mukhtar Ijaiya (18935122)

"…Merged demographic, clinic, pharmacy, and laboratory data were included as potential predictor variables in multiple models. …"

Flow chart of data source inclusion. حسب Mukhtar Ijaiya (18935122)

"…Merged demographic, clinic, pharmacy, and laboratory data were included as potential predictor variables in multiple models. …"

Predictive model-building process. حسب Mukhtar Ijaiya (18935122)

"…Merged demographic, clinic, pharmacy, and laboratory data were included as potential predictor variables in multiple models. …"

Comparison of models performance metrics. حسب Mukhtar Ijaiya (18935122)

"…Merged demographic, clinic, pharmacy, and laboratory data were included as potential predictor variables in multiple models. …"

Sample multi-parameter patient data from the MIMIC-III clinical database: This figure demonstrates the complicated, high-resolution time-series data monitored on a single patient o... حسب Medhat A. Tawfeek (22522087)

Schematic overview of the XBSI framework. حسب Rajeev Bopche (20208606)

Comparative performance metrics of ML models. حسب Rajeev Bopche (20208606)

"…Olavs Hospital in Trondheim, Norway, encompassing 35,591 patients, the framework integrates demographic, laboratory, and comprehensive medical history data to classify patients into high-risk and low-risk BSI groups. …"